NCT04057300View on ClinicalTrials.gov

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes

PHASE4CompletedINTERVENTIONAL
Enrollment

1,038

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2023

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Ticagrelor 90mg

Ticagrelor tablet

DRUG

Clopidogrel 75mg

Clopidogrel tablet

DRUG

acetylsalicylic acid (ASA) 81mg

acetylsalicylic acid tablet

Trial Locations (1)

Unknown

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT04057300 - Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes | Biotech Hunter | Biotech Hunter